Correlation between Pancreatic Cancer and Diabetes - brief review of the last 5 years


  • Isadora de Souza Alvim
  • Gabriela Bochner de Faria
  • Lídia Leme Justino Drago
  • Rafaella Antunes dos Santos
  • Cristóvão Marcondes de Castro Rodrigues



Diabetes Mellitus, pancreatic neoplasms, glycemia control, hyperglycemia, pâncreas


Diabetes mellitus is a group of metabolic diseases defined by persistent hyperglycemia. Severe hyperglycemia leads to classic symptoms such as polyuria, polydipsia, fatigue, and decreased performance. This condition presents, different classifications considering its possible etiologies, being four subtypes: type 1, type 2, gestational and other specific forms of diabetes type 3c. It is suggested that there is a strong association between diabetes mellitus (especially type 2 diabetes mellitus) and carcinogenesis, but this correlation is still underestimated during the diagnosis of diabetes. This paper aims to review the literature on the PubMed search platform for papers from the last five years on the correlation between pancreatic cancer and diabetes; through the adoption of specific descriptors and rigorous selection criteria of the selected articles to be used as a basis, and thus a total of twenty two articles fit to carry out this work. Based on the current literature, several studies have suggested that diabetes mellitus and cancer are often coexisting diseases, but they are rarely diagnosed concurrently and consequently make treatment difficult and the prognosis tends to be unfavorable, which makes greater disclosure about the correlation essential. among such diseases, aiming at a better diagnosis in a systematic way, and thus making the patient's prognosis more reliable.


- Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018 Feb;14(2):88-98. doi: 10.1038/nrendo.2017.151. Epub 2017 Dec 8. PMID: 29219149.

- Wojciechowska J, Krajewski W, Bolanowski M, Kręcicki T, Zatoński T. Diabetes and Cancer: a Review of Current Knowledge. Exp Clin Endocrinol Diabetes. 2016 May;124(5):263-75. doi: 10.1055/s-0042-100910. Epub 2016 May 24. PMID: 27219686

- Harreiter J, Roden M. Diabetes mellitus – Definition, Klassifikation, Diagnose, Screening und Prävention (Update 2019) [Diabetes mellitus-Definition, classification, diagnosis, screening and prevention (Update 2019)]. Wien Klin Wochenschr. 2019 May;131(Suppl 1):6-15. German. doi: 10.1007/s00508-019-1450-4. PMID: 30980151.

- The American Diabetes Association(ADA). 2.Classification and diagnosis of diabetes: Standards of medical care in diabetes–2018. Diabetes Care. 2018;41(Suppl 1):S13–S27.doi: 10.2337/dc18-S002.

- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8. PMID: 31912902.

- Cracco EF, Bilinski VR, Pavanello A. Análise do perfil epidemiológico de óbitos por Diabetes Mellitus no estado do Paraná no ano de 2021 . Braz. J. Hea. Rev. 2023 Sep. 21 [cited 2023 Oct. 3];6(5):22600-14. doi: 10.34119/bjhrv6n5-289

- Silva Júnior AMR, Sousa EC. Tumor sólido pseudopapilar do pâncreas. Braz. J. Hea. Rev. 2023. doi: 10.34119/bjhrv6n4-239

- Pereira SP, Oldfield L, Ney A, et al. Early detection of pancreatic cancer. Lancet Gastroenterol Hepatol 2020; published online March 2. doi:10.1016/S2468–1253(19)30416–9.

- American Diabetes Association. 2. Classification and diagnosis of diabetes. Diabetes Care. 2016; 39(suppl 1):S13–22. [PubMed: 26696675]

- Hart PA, Bellin MD, Andersen DK, Bradley D, Cruz-Monserrate Z, Forsmark CE, Goodarzi MO, Habtezion A, Korc M, Kudva YC, Pandol SJ, Yadav D, Chari ST; Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer(CPDPC). Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer. Lancet Gastroenterol Hepatol. 2016 Nov;1(3):226-237. doi: 10.1016/S2468-1253(16)30106-6. Epub 2016 Oct 12. PMID: 28404095; PMCID: PMC5495015.

- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12. Erratum in: CA Cancer J Clin. 2020 Jul;70(4):313. PMID: 30207593.

- Rawla P, Sunkara T, Gaduputi V. Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors. World J Oncol. 2019 Feb;10(1):10-27. doi: 10.14740/wjon1166. Epub 2019 Feb 26. PMID: 30834048; PMCID: PMC6396775.

- Dooley J, Tian L, Schonefeldt S, Delghingaro-Augusto V, Garcia-Perez JE, Pasciuto E, Di Marino D, Carr EJ, Oskolkov N, Lyssenko V, Franckaert D, Lagou V, Overbergh L, Vandenbussche J, Allemeersch J, Chabot-Roy G, Dahlstrom JE, Laybutt DR, Petrovsky N, Socha L, Gevaert K, Jetten AM, Lambrechts D, Linterman MA, Goodnow CC, Nolan CJ, Lesage S, Schlenner SM, Liston A. Genetic predisposition for beta cell fragility underlies type 1 and type 2 diabetes. Nat Genet. 2016 May;48(5):519-27. doi: 10.1038/ng.3531. Epub 2016 Mar 21. PMID: 26998692; PMCID: PMC5584070.

- Zimmet P, Alberti KG, Magliano DJ, Bennett PH. Diabetes mellitus statistics on prevalence and mortality: facts and fallacies. Nat Rev Endocrinol. 2016 Oct;12(10):616-22. doi: 10.1038/nrendo.2016.105. Epub 2016 Jul 8. PMID: 27388988.

- Moz S, Basso D, Padoan A, Bozzato D, Fogar P, Zambon CF, Pelloso M, Sperti C, Vigili de Kreutzenberg S, Pasquali C, Pedrazzoli S, Avogaro A, Plebani M. Blood expression of matrix metalloproteinases 8 and 9 and of their inducers S100A8 and S100A9 supports diagnosis and prognosis of PDAC-associated diabetes mellitus. Clin Chim Acta. 2016 May 1; 456:24-30. doi: 10.1016/j.cca.2016.02.018. Epub 2016 Mar 1. PMID: 26923392.

- Wu W, He X, Yang L, Wang Q, Bian X, Ye J, Li Y, Li L. Rising trends in pancreatic cancer incidence and mortality in 2000-2014. Clin Epidemiol. 2018 Jul 9; 10:789-797. doi: 10.2147/CLEP.S160018. PMID: 30022856; PMCID: PMC6042490.

- Mizrahi JD, Surana R, Valle JW, Shroff RT. Pancreatic cancer. Lancet. 2020 Jun 27;395(10242):2008-2020. doi: 10.1016/S0140-6736(20)30974-0. PMID: 32593337.

- Singhi AD, Koay EJ, Chari ST, Maitra A. Early Detection of Pancreatic Cancer: Opportunities and Challenges. Gastroenterology. 2019 May;156(7):2024-2040. doi: 10.1053/j.gastro.2019.01.259. Epub 2019 Feb 2. PMID: 30721664; PMCID: PMC6486851.

- Ilic M, Ilic I. Epidemiology of pancreatic cancer. World J Gastroenterol. 2016 Nov 28;22(44):9694-9705. doi: 10.3748/wjg.v22.i44.9694. PMID: 27956793; PMCID: PMC5124974.

- Khadka R, Tian W, Hao X, Koirala R. Risk factor, early diagnosis and overall survival on outcome of association between pancreatic cancer and diabetes mellitus: Changes and advances, a review. Int J Surg. 2018 Apr; 52:342-346. doi: 10.1016/j.ijsu.2018.02.058. Epub 2018 Mar 10. PMID: 29535016.

- Scholten L, Stoop TF, Del Chiaro M, Busch OR, van Eijck C, Molenaar IQ, de Vries JH, Besselink MG; Dutch Pancreatic Cancer Group. Systematic review of functional outcome and quality of life after total pancreatectomy. Br J Surg. 2019 Dec;106(13):1735-1746. doi: 10.1002/bjs.11296. Epub 2019 Sep 10. PMID: 31502658; PMCID: PMC6899549.

- O'Reilly EM, Oh DY, Dhani N, Renouf DJ, Lee MA, Sun W, Fisher G, Hezel A, Chang SC, Vlahovic G, Takahashi O, Yang Y, Fitts D, Philip PA. Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma: A Phase 2 Randomized Clinical Trial. JAMA Oncol. 2019 Oct 1;5(10):1431-1438. doi: 10.1001/jamaoncol.2019.1588. PMID: 31318392; PMCID: PMC6647002.

- Upadhrasta S, Zheng L. Strategies in Developing Immunotherapy for Pancreatic Cancer: Recognizing and Correcting Multiple Immune "Defects" in the Tumor Microenvironment. J Clin Med. 2019 Sep 16;8(9):1472. doi: 10.3390/jcm8091472. PMID: 31527414; PMCID: PMC6780937.

- Golan T, Hammel P, Reni M, Van Cutsem E, Macarulla T, Hall MJ, Park JO, Hochhauser D, Arnold D, Oh DY, Reinacher-Schick A, Tortora G, Algül H, O'Reilly EM, McGuinness D, Cui KY, Schlienger K, Locker GY, Kindler HL. Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer. N Engl J Med. 2019 Jul 25;381(4):317-327. doi: 10.1056/NEJMoa1903387. Epub 2019 Jun 2. PMID: 31157963; PMCID: PMC6810605.




How to Cite

Alvim, I. de S., de Faria, G. B., Drago, L. L. J., dos Santos, R. A., & Rodrigues, C. M. de C. (2023). Correlation between Pancreatic Cancer and Diabetes - brief review of the last 5 years. Brazilian Journal of Health Review, 6(6), 28529–28537.



Original Papers